Global In Vitro Fertilization Banking Services Market Report and Forecast 2024-2032

Global In Vitro Fertilization Banking Services Market Report and Forecast 2024-2032


Global In Vitro Fertilization Banking Services Market Outlook

The global in vitro fertilization banking services market size was valued at USD 4.3 billion in 2023, driven by prevalence of infertility across the globe. The market size is anticipated to grow at a CAGR of 10.5% during the forecast period of 2024-2032 to achieve a value of about USD 10.6 billion by 2032.

In Vitro Fertilization Banking Services: Introduction

In-vitro fertilization (IVF) banking services refer to a specialized approach in assisted reproductive technology (ART) that involves the storage and management of frozen embryos, oocytes (eggs), and sperm for future use in fertility treatments. IVF banking services provide individuals and couples with the option to preserve their reproductive cells and embryos for later use, allowing them to extend their fertility window or overcome fertility challenges.

IVF banking services have revolutionized the field of reproductive medicine by offering a comprehensive and efficient approach to fertility preservation and treatment. These services provide individuals with the opportunity to store their reproductive cells and embryos when they are at their peak fertility or before undergoing certain medical treatments that may affect their fertility. The stored specimens can be used in the future for fertility treatment, such as IVF or intrauterine insemination (IUI), increasing the chances of achieving a successful pregnancy.

Key Trends in the Global In Vitro Fertilization Banking Services Market

The in vitro fertilization (IVF) banking services market is influenced by several key trends that are shaping the industry. These trends include:
  • Increasing Demand for Fertility Preservation: There is a growing awareness and demand for fertility preservation options, including IVF banking services. This trend is driven by factors such as delayed childbearing due to career or personal reasons, advancements in reproductive technologies, and the desire to preserve fertility before undergoing medical treatments that may affect fertility.
  • Technological Advancements in Cryopreservation Techniques: Cryopreservation techniques, such as vitrification, have significantly improved the success rates of preserving embryos, eggs, and sperm. These advancements have led to higher survival rates and better post-thaw outcomes, increasing the confidence in IVF banking services.
  • Growing Popularity of Elective Single Embryo Transfer (eSET): The practice of eSET, where a single high-quality embryo is transferred during IVF treatment, is gaining popularity. This trend is driven by efforts to reduce the incidence of multiple pregnancies and associated risks.
  • Expansion of Third-Party Reproduction Services: IVF banking services are often utilized in conjunction with third-party reproduction methods, such as egg or sperm donation and gestational surrogacy. IVF banking services play a crucial role in coordinating and managing the storage of reproductive cells in these complex reproductive arrangements.
  • Rising Popularity of Genetic Testing: The integration of genetic testing techniques, such as preimplantation genetic testing (PGT), with IVF treatments is becoming more common. PGT allows for the screening of embryos for genetic disorders before transfer, improving the chances of a successful pregnancy and reducing the risk of certain genetic conditions.
Global In Vitro Fertilization Banking Services Market Segmentations

The market can be categorised into service type, egg cycle, and region.

Market Breakup by Service Type
  • Egg Banking
  • Sperm Banking
  • Others
Market Breakup by Donor Egg Cycle
  • Fresh Donor Egg Cycle
  • Frozen Donor Egg Cycle
Market Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Global In Vitro Fertilization Banking Services Market Overview

The IVF banking services market has been experiencing significant growth in recent years. The increasing prevalence of infertility, advancements in ART techniques, and growing awareness about fertility preservation options are driving the expansion of the market. Additionally, societal factors such as delayed childbearing and the rising acceptance of ART technologies are contributing to the market's growth.

The market for IVF banking services is global in nature, with a presence in major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Developed regions, such as North America and Europe, have well-established markets due to advanced healthcare infrastructure, higher awareness, and greater affordability. The Asia Pacific region is witnessing significant growth due to improving healthcare facilities, increasing disposable incomes, and rising awareness about fertility preservation.

Key Players in the In Vitro Fertilization Banking Services Market

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in in vitro fertilization banking services market are as follows:
  • Seattle Sperm Bank
  • European Sperm Bank
  • My Eggbank
  • Dunya IVF: Cyprus Fertility Clinic
  • CCRM Fertility
  • California Cryobank
  • The World Egg Bank
  • Cryos International
  • Genetics and IVF Institutes
  • Boston IVF, Inc.
We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.


1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global In Vitro Fertilization Banking Services Market Overview
3.1 Global In Vitro Fertilization Banking Services Market Historical Value (2017-2023)
3.2 Global In Vitro Fertilization Banking Services Market Forecast Value (2024-2032)
4 Global In Vitro Fertilization Banking Services Market Landscape
4.1 Lentiviral Vectors: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Lentiviral Vectors: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Applications
5 Global In Vitro Fertilization Banking Services Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global In Vitro Fertilization Banking Services Market Segmentation
6.1 Global In Vitro Fertilization Banking Services Market by Service Type
6.1.1 Market Overview
6.1.2 Egg banking
6.1.3 Sperm banking
6.1.4 Others
6.2 Global In Vitro Fertilization Banking Services Market by Donor Egg Cycle
6.2.1 Market Overview
6.2.2 Fresh Donor Egg Cycle
6.2.3 Frozen Donor Egg Cycle
6.3 Global In Vitro Fertilization Banking Services Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America In Vitro Fertilization Banking Services Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe In Vitro Fertilization Banking Services Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific In Vitro Fertilization Banking Services Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America In Vitro Fertilization Banking Services Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa In Vitro Fertilization Banking Services Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Seattle Sperm Bank
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 European Sperm Bank
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 My Eggbank
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 Dunya IVF: Cyprus Fertility Clinic
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 CCRM Fertility
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 California Cryobank
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 The World Egg Bank
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 Cryos International
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 Genetics and IVF Institutes
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 Boston IVF, Inc.
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings